Showing results (461-470 of 559) with videos related to

Sort By:
Pageof 56
Blood|February 26, 2026
Differential role of CREBBP missense and truncating mutations in germinal center development and lymphomagenesisChuanjiang Yu, Mara Holloman, Andrew Kim, et al.
Frontiers in Immunology|March 29, 2021
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 AntibodySimon Gebremeskel, Julia Schanin, Krysta M Coyle, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
Bioinformatics (Oxford, England)|February 5, 2010
SNVMix: predicting single nucleotide variants from next-generation sequencing of tumorsRodrigo Goya, Mark G F Sun, Ryan D Morin, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2018
A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical SpecimensMiguel Alcaide, Matthew Cheung, Kevin Bushell, et al.
Blood|March 6, 2013
Analysis of FOXO1 mutations in diffuse large B-cell lymphomaDiane L Trinh, David W Scott, Ryan D Morin, et al.
Oncotarget|November 8, 2012
Recurrent targets of aberrant somatic hypermutation in lymphomaAlireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, et al.
Oncotarget|May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutationsChenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
European Journal of Pharmacology|July 23, 1997
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptorsY Ala, D Morin, E Mahé, et al.
The Journal of Clinical Investigation|November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyLeandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Pageof 56